Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by GREER R SCOTT, Director. Director active across 3 companies, notably Inogen Inc. In total, 10 filings have been published. History available since 10 May 2021. The latest transaction was disclosed on 16 September 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
10 of 10 declarations
Scott R. Greer is a Board Member at Inogen Inc and Nektar Therapeutics. He plays a key role in corporate governance and development strategy for both companies. His experience in the healthcare sector allows him to provide significant contributions to the strategic direction and growth of the firms.